Published

08 Aug 25

Updated

16 Jun 26

Views

58

Not Invested

Evolv Technologies HoldingsEVLV

Fair Value

US$10.5

Share price16 Jun

US$5.4847.8% undervalued

Loading

1Y-16.40%

7D3.98%

Urbanization And AI Will Revolutionize Touchless Screening

AN

AnalystHighTarget

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published

08 Aug 25

Updated

16 Jun 26

Views

58

Not Invested

Shared on 16 Jun 26

EVLV: SAFETY Act Wins And 2026 Manufacturing Ramp Will Drive Upside

Evolv says demand is picking up as more schools, hospitals, and venues roll out its touchless weapons-screening systems, helped by clearer messaging after earlier confusion in reported results. A key government safety designation and a planned manufacturing ramp could improve how much money the company keeps from each sale over time.

9 views

Shared on 18 Apr 26

EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.

3 views

Shared on 20 Mar 26

Fair value Increased 5.00%

EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside

Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.

5 views

Shared on 06 Mar 26

EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).

3 views

Shared on 05 Feb 26

EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case

Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.

3 views

Shared on 08 Jan 26

Fair value Increased 21%

EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook

Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.

5 views

Fair Value vs Share Price

US$10.5

vs US$5.4847.8% undervalued

19.3%

Revenue growth

8.3%

Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Evolv Technologies Holdings

Fair value estimate changes
Narrative and analyst updates
Key company announcements

Company analysis

Flawless balance sheet and slightly overvalued.

Market capUS$985.7m

PB8.2x

Estimated Growth15.5%

Dividend YieldN/A

CEO & management

John Kedzierski

CEO

2.0yrs

CEO Tenure

Develops, manufactures, markets, and sells security screening products and specific services in the United States and internationally.